Abstract
Topiramate is an antiepileptic agent, which is being investigated as a mood-stabilizer. Three obese individuals with DSM-IV bipolar I disorder and type II diabetes mellitus received topiramate treatment in combination with antipsychotics and valproate or carbamazepine. In addition to improved mood stability, these individuals lost between 16 to 20.5% of their pre-topiramate body weight and also achieved significant glycemic control.
Original language | English |
---|---|
Pages (from-to) | 186-190 |
Number of pages | 5 |
Journal | European Psychiatry |
Volume | 16 |
Issue number | 3 |
DOIs | |
State | Published - 1 Jan 2001 |
Externally published | Yes |
Keywords
- Bipolar disorder
- Body mass index
- Diabetes mellitus
- Topiramate
- Weight loss
ASJC Scopus subject areas
- Psychiatry and Mental health